NovaBay Pharmaceuticals (NBY) Earnings Date, Estimates & Call Transcripts

$0.08
0.00 (0.00%)
(As of 04/25/2024 ET)

Earnings Summary

Latest
Earnings Date
Mar. 26Estimated
Actual EPS
(Mar. 26)
-$0.95 Missed By -$0.95
Skip Charts & View Estimated and Actual Earnings Data

NBY Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

NBY Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

NovaBay Pharmaceuticals Analyst EPS Estimates

Current Year EPS Consensus Estimate:($0.41) EPS
Next Year EPS Consensus Estimate: $0.07 EPS

NBY Earnings Date and Information

NovaBay Pharmaceuticals last announced its earnings results on March 26th, 2024. The reported ($0.95) EPS for the quarter. The company earned $3.73 million during the quarter. NovaBay Pharmaceuticals has generated ($3.82) earnings per share over the last year (($3.82) diluted earnings per share). Earnings for NovaBay Pharmaceuticals are expected to grow in the coming year, from ($0.41) to $0.07 per share.

NovaBay Pharmaceuticals Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
3/26/2024Q4 2023-($0.95)($0.95)($0.57)-$3.73 million    
11/9/2023Q3 2023-($0.37)($0.37)($0.37)-$3.27 million
8/10/2023Q2 2023-($1.27)($1.27)($1.27)-$4.61 million
5/11/2023Q1 2023-($0.85)($0.85)($0.85)-$3.12 million
3/30/2023Q4 2022-($4.33)($4.33)($4.33)-$3.64 million
11/14/2022Q3 2022-($3.50)($3.50)($3.50)-$3.83 million
8/11/2022Q2 2022-($1.40)($1.40)($1.40)-$3.05 million
3/29/2022Q4 2021-($0.70)($0.70)($0.70)-$2.64 million
11/11/2021Q3 2021-($1.75)($1.75)($1.75)-$1.84 million
8/12/2021Q2 2021-($1.40)($1.40)($1.40)-$2.13 million
5/6/2021Q1 2021-($1.40)($1.40)($1.40)-$1.81 million

NovaBay Pharmaceuticals Earnings - Frequently Asked Questions

When did NovaBay Pharmaceuticals announce their last quarterly earnings?

NovaBay Pharmaceuticals (NYSE:NBY) last announced its quarterly earning data on Tuesday, March 26, 2024. Learn more on NBY's earnings history.

How can I listen to NovaBay Pharmaceuticals's earnings conference call?

The conference call for NovaBay Pharmaceuticals's latest earnings report can be listened to online. Listen to Conference Call

How can I read NovaBay Pharmaceuticals's conference call transcript?

The conference call transcript for NovaBay Pharmaceuticals's latest earnings report can be read online. Read Transcript

How much revenue does NovaBay Pharmaceuticals generate each year?

NovaBay Pharmaceuticals (NYSE:NBY) has a recorded annual revenue of $14.73 million.

How much profit does NovaBay Pharmaceuticals generate each year?

NovaBay Pharmaceuticals (NYSE:NBY) has a recorded net income of -$9.64 million. NBY has generated -$3.82 earnings per share over the last four quarters.

What is NovaBay Pharmaceuticals's EPS forecast for next year?

NovaBay Pharmaceuticals's earnings are expected to grow from ($0.41) per share to $0.07 per share in the next year.


More Earnings Resources from MarketBeat

This page (NYSE:NBY) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners